Noven Therapeutics
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.daytrana.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Noven Therapeutics
Noven Therapeutics, LLC specializes in the development of DAYTRANA®, a transdermal system designed for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in children and adolescents ages 6 to 17. The DAYTRANA patch provides a long-acting solution that can be easily adjusted for individual needs, offering a maximum wear time of 9 hours with up to 10 hours of efficacy. Intended clients include children diagnosed with ADHD and their healthcare providers seeking effective therapeutic options. Important safety information is provided regarding potential side effects and the correct use of the medication.Explore more
Popular SearchesNoven Therapeutics LLCDaytranaDaytrana ®( methylphenidateSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Noven Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Noven Therapeutics is spiking on competitors!
Product Launch: Get notified when Noven Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Noven Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Noven Therapeutics
Noven Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Noven Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Noven Therapeutics has new funding data
Earning: See what the market has to say on Noven Therapeutics recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Noven Therapeutics
Compare insights from companies similar to Noven Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Noven Therapeutics
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Noven Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Noven Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Noven Therapeutics.
Noven Therapeutics Tech Stack
A closer look at the technologies used by Noven Therapeutics
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Noven Therapeutics
Sign Up For FreeTo access detailed company insights
Noven Therapeutics, LLC specializes in the development of DAYTRANA®, a transdermal system designed for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in children and adolescents ages 6 to 17. The DAYTRANA patch provides a long-acting solution that can be easily adjusted for individual needs, offering a maximum wear time of 9 hours... Read More
